Academic literature on the topic 'Pregnancy Complications Australia'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pregnancy Complications Australia.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Pregnancy Complications Australia"
1
Taylor, Lee, Delyse Hutchinson, Ron Rapee, Lucy Burns, Christine Stephens, and Paul S. Haber. "Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service." Obstetrics and Gynecology International 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/867265.
Full textAbstract:
Background. There is a paucity of research in Australia on the characteristics of women in treatment for illicit substance use in pregnancy and the health outcomes of their neonates.Aims. To determine the clinical features and outcomes of high-risk, marginalized women seeking treatment for illicit substance use in pregnancy and their neonates.Methods. 139 women with a history of substance abuse/dependence engaged with a perinatal drug health service in Sydney, Australia. Maternal (demographic, drug use, psychological, physical, obstetric, and antenatal care) and neonatal characteristics (delivery, early health outcomes) were examined.Results. Compared to national figures, pregnant women attending a specialist perinatal and family drug health service were more likely to report being Australian born, Aboriginal or Torres Strait Islander, younger, unemployed, and multiparous. Opiates were the primary drug of concern (81.3%). Pregnancy complications were common (61.9%). Neonates were more likely to be preterm, have low birth weight, and be admitted to special care nursery. NAS was the most prevalent birth complication (69.8%) and almost half required pharmacotherapy.Conclusion. Mother-infant dyads affected by substance use in pregnancy are at significant risk. There is a need to review clinical models of care and examine the longer-term impacts on infant development.
2
Melody, Shannon M., Karen Wills, Luke D. Knibbs, Jane Ford, Alison Venn, and Fay Johnston. "Maternal Exposure to Ambient Air Pollution and Pregnancy Complications in Victoria, Australia." International Journal of Environmental Research and Public Health 17, no. 7 (April 9, 2020): 2572. http://dx.doi.org/10.3390/ijerph17072572.
Full textAbstract:
The relationship between maternal exposure to ambient air pollution and pregnancy complications is not well characterized. We aimed to explore the relationship between maternal exposure to ambient nitrogen dioxide (NO2) and fine particulate matter (PM2.5) and hypertensive disorders of pregnancy, gestational diabetes mellitus (GDM) and placental abruption. Using administrative data, we defined a state-wide cohort of singleton pregnancies born between 1 March 2012 and 31 December 2015 in Victoria, Australia. Annual average NO2 and PM2.5 was assigned to maternal residence at the time of birth. 285,594 singleton pregnancies were included. An IQR increase in NO2 (3.9 ppb) was associated with reduced likelihood of hypertensive disorders of pregnancy (RR 0.89; 95%CI 0.86, 0.91), GDM (RR 0.92; 95%CI 0.90, 0.94) and placental abruption (RR 0.81; 95%CI 0.69, 0.95). Mixed observations and smaller effect sizes were observed for IQR increases in PM2.5 (1.3 µg/m3) and pregnancy complications; reduced likelihood of hypertensive disorders of pregnancy (RR 0.95; 95%CI 0.93, 0.97), increased likelihood of GDM (RR 1.02; 95%CI 1.00, 1.03) and no relationship for placental abruption. In this exploratory study using an annual metric of exposure, findings were largely inconsistent with a priori expectations and further research involving temporally resolved exposure estimates are required.
3
CHEN, CHIEN-YI, and MEI-HWEI CHANG. "HEPATITIS B AND PREGNANCY, THE SCIENTIFIC BASIS FOR PERINATAL PREVENTION." Fetal and Maternal Medicine Review 21, no. 2 (March 15, 2010): 89–113. http://dx.doi.org/10.1017/s0965539510000021.
Full textAbstract:
Hepatitis B and its complications are one of the major global health problems. Around 2 billion individuals are infected by hepatitis B virus (HBV) worldwide, more than 350 million are chronically infected, and approximately 15 to 40 percents of them will develop serious complications such as liver cirrhosis, hepatic failure, or hepatocellular carcinoma (HCC). The worldwide prevalence of chronic HBV infection ranges from 0.1 to 20 percent and varies widely in different geographic areas. According to the prevalence rate, WHO has classified countries into 3 levels: high areas (>8%) such as Africa, Asia, Western Pacific and Middle East; intermediate areas (2–8%) such as South America and Eastern Europe, and low areas (<2%) such as Western Europe, North America, and Australia.
4
Nossent, Johannes, Warren Raymond, Helen Keen, Charles Inderjeeth, and David Preen. "Pregnancy outcomes in women with a history of immunoglobulin A vasculitis." Rheumatology 58, no. 5 (December 24, 2018): 884–88. http://dx.doi.org/10.1093/rheumatology/key408.
Full textAbstract:
Abstract Objectives Case series suggest an increased risk of pregnancy complications in women with a history of IgA vasculitis (IgAV); however, no large quantitative studies have examined this possible association to date. We compared pregnancy rates and outcomes between female IgAV patients and controls and assessed flare risk of IgAV during pregnancy. Methods Using state-wide hospital morbidity data we compared rates for live birth, preterm birth, abortive outcome and gestational complications between female IgAV patients (International Classification of Diseases-9-Clinical Modification 287.0; International Classification of Diseases-10-Australian Modification D69.0) (n = 121) and non-exposed age-matched controls (n = 284) in Western Australia. Results presented are means compared by Kruskal–Wallis test and proportions with odds ratios (ORs) (95% CI) compared by χ2 testing. Results There were 247 pregnancies in IgAV patients during which no disease flares were recorded and 556 pregnancies in controls. IgAV patients were younger at first pregnancy (24.7 vs 27.0 years, P < 0.01) and had 43 unsuccessful pregnancies (17.4%) and 204 live births with 17 preterm deliveries (8.3%). Women with IgAV had increased odds of spontaneous abortion (OR 1.9, 95% CI 1.1, 3.1, P = 0.04), preterm delivery (OR 2.0, 95% CI 1.1, 3.9, P = 0.02) and gestational hypertension (OR 4.7, 95% CI 2.3, 9.8). While gravidity did not differ (mean pregnancy number 2.4 vs 2.3, P = 0.36), IgAV patients had over a two-fold greater number of obstetric visits than controls (5.1 vs 2.5, P < 0.01). Conclusions Hospitalization for IgAV has little impact on fertility and IgAV rarely flares during pregnancy. However, a history of IgAV associates with increased odds of spontaneous abortions, gestational hypertension and preterm delivery.
5
Gebremedhin, Amanuel Tesfay, Gizachew Assefa Tessema, Annette K. Regan, and Gavin F. Pereira. "Association between interpregnancy interval and pregnancy complications by history of complications: a population-based cohort study." BMJ Open 11, no. 12 (December 2021): e046962. http://dx.doi.org/10.1136/bmjopen-2020-046962.
Full textAbstract:
ObjectiveTo examine if the association between interpregnancy interval (IPI) and pregnancy complications varies by the presence or absence of previous complications.Design and settingPopulation-based longitudinally linked cohort study in Western Australia (WA).ParticipantsMothers who had their first two (n=252 368) and three (n=96 315) consecutive singleton births in WA between 1980 and 2015.Outcome measuresWe estimated absolute risks (AR) of preeclampsia (PE) and gestational diabetes (GDM) for 3–60 months of IPI according to history of each outcome. We modelled IPI using restricted cubic splines and reported adjusted relative risk (RRs) with 95% CI at 3, 6, 12, 24, 36, 48 and 60 months, with 18 months as reference.ResultsRisks of PE and GDM were 9.5%, 2.6% in first pregnancies, with recurrence rates of 19.3% and 41.5% in second pregnancy for PE and GDM, respectively. The AR of GDM ranged from 30% to 43% across the IPI range for mothers with previous GDM compared with 2%–8% for mothers without previous GDM. For mothers with no previous PE, greater risks were observed for IPIs at 3 months (RR 1.24, 95% CI 1.07 to 1.43) and 60 months (RR 1.40, 95% CI 1.29 to 1.53) compared with 18 months. There was insufficient evidence for increased risk of PE at shorter IPIs of <18 months for mothers with previous PE. Shorter IPIs of <18 months were associated with lower risk than at IPIs of 18 months for mothers with no previous GDM.ConclusionsThe associations between IPIs and risk of PE or GDM on subsequent pregnancies are modified by previous experience with these conditions. Mothers with previous complications had higher absolute, but lower RRs than mothers with no previous complications. However, IPI remains a potentially modifiable risk factor for mothers with previous complicated pregnancies.
6
Luccisano, Sharon P., Heinrich C. Weber, Giuliana O. Murfet, Iain K. Robertson, Sarah J. Prior, and Andrew P. Hills. "An Audit of Pre-Pregnancy Maternal Obesity and Diabetes Screening in Rural Regional Tasmania and Its Impact on Pregnancy and Neonatal Outcomes." International Journal of Environmental Research and Public Health 18, no. 22 (November 16, 2021): 12006. http://dx.doi.org/10.3390/ijerph182212006.
Full textAbstract:
Maternal obesity in pregnancy, a growing health problem in Australia, adversely affects both mothers and their offspring. Gestational diabetes mellitus (GDM) is similarly associated with adverse pregnancy and neonatal complications. A low-risk digital medical record audit of antenatal and postnatal data of 2132 pregnant mothers who gave birth between 2016–2018 residing in rural-regional Tasmania was undertaken. An expert advisory group guided the research and informed data collection. Fifty five percent of pregnant mothers were overweight or obese, 43.6% gained above the recommended standards for gestational weight gain and 35.8% did not have an oral glucose tolerance test. The audit identified a high prevalence of obesity among pregnant women and low screening rates for gestational diabetes mellitus associated with adverse maternal and neonatal pregnancy outcomes. We conclude that there is a high prevalence of overweight and obesity among pregnant women in rural regional Tasmania. Further GDM screening rates are low, which require addressing.
7
Croft, Maxine L., Vera Morgan, Anne W. Read, and Assen S. Jablensky. "Recorded Pregnancy Histories of the Mothers of Singletons and the Mothers of Twins: A Longitudinal Comparison." Twin Research and Human Genetics 13, no. 6 (December 1, 2010): 595–603. http://dx.doi.org/10.1375/twin.13.6.595.
Full textAbstract:
A population-based record linkage case cohort of 239,995 births, to 119,214 women, born in Western Australia from 1980 to 2001 inclusive, was used to measure the recording of selected indicators of maternal health (current and prior) during pregnancy. We compared records of women with singleton pregnancies with that in twin pregnancies Mothers of first- and second-born singletons (n= 117,647) were compared with women with a first-born singleton followed by twins (n= 1,567). Binary indicators were used to calculate population prevalence of medical conditions, pregnancy complications and birth outcomes. Infant outcomes included stillbirth, low birthweight, preterm birth and birth defects. Women with twins were significantly older and taller, with similar rates of medical conditions and pregnancy complications during first singleton pregnancies compared with women with two consecutive singletons. However, during their second pregnancy, women with twins had significantly higher rates of essential hypertension, pre-eclampsia, threatened abortion, premature rupture of the membranes and ante partum hemorrhage with abruption than women with singletons. For both groups, maternal conditions in the first pregnancy were underreported in the second pregnancy, including diabetes, epilepsy, asthma, chronic renal dysfunction and essential hypertension. At the second birth, twins were 3 times more likely to be stillborn, 17 times more likely to be low birthweight and 4 times more likely to be delivered preterm compared with singletons. This research demonstrates the importance for epidemiologists and others, of having access to a complete maternal medical history for analyses of risks associated with maternal, infant and childhood morbidity.
8
Thompson, S. D., R. C. Nowak, J. Zhang, G. A. Dekker, and C. T. Roberts. "278. IGF2 polymorphisms predict pregnancy outcome." Reproduction, Fertility and Development 20, no. 9 (2008): 78. http://dx.doi.org/10.1071/srb08abs278.
Full textAbstract:
IGF-II is an important determinant of placental trophoblast invasion and subsequent placental function. IGF-II can act in autocrine/paracrine and endocrine fashions to promote placental invasion and differentiation and within both the fetus and placenta to promote fetal growth. We aimed to determine whether polymorphisms in Igf2 are associated with common pregnancy complications associated with uteroplacental insufficiency. Pregnant women were recruited in early pregnancy for a prospective case control study at the Women's and Children's Hospital and Lyell McEwin Health Service, Adelaide, Australia. Buffy coats were retrieved from maternal blood sampled at 15 weeks gestation, paternal blood and cord blood collected following delivery. Pregnancy outcomes were classified into normal (n = 126), preeclampsia (PE, n = 31), gestational hypertension (GH, n = 18), small-for-gestational-age (SGA, n = 50), PE+SGA (n = 16) or preterm birth (PTB, n = 19) by an experienced obstetrician. Three polymorphisms in Igf2, Igf2 ApaI and Igf2 MspI single nucleotide polymorphisms, and INS+2336 deletion/insertion polymorphism were selected for investigation. DNA was extracted from buffy coats and genotyping was performed by PCR followed by High Resolution Melt analyses. Data were analysed by Chi Square and Fisher's Exact Test and Likelihood Ratios (LR) were calculated. In normal pregnancies, all polymorphisms were in Hardy–Weinberg Equilibrium. Igf2 ApaI in the neonate, and hence placenta, was associated with PE (P = 0.016, LR = 7.46) and PTB (P = 0.024, LR = 8.61). Neonatal Igf2 MspI was associated with SGA (P = 0.007, LR = 9.81). Gestational age was associated with maternal Igf2 ApaI (P = 0.0004) and INS+2336 (P = 0.0021), as well as neonatal INS+2336 (P = 0.0046). Birthweight was associated with paternal Igf2 MspI (P = 0.044) when corrected for gestational age. Although this work is ongoing, data thus far suggest polymorphisms in the gene encoding IGF-II, primarily in the placenta, are associated with a range of pregnancy complications which have been associated with impaired placental function. Ongoing research will determine whether these polymorphisms are associated with aberrant placental Igf2 expression.
9
Rao, Nitesh N., Chris Wilkinson, Mark Morton, Greg D. Bennett, Graeme R. Russ, Patrick T. Coates, and Shilpa Jesudason. "Successful pregnancy in a recipient of an ABO-incompatible renal allograft." Obstetric Medicine 12, no. 1 (March 7, 2018): 42–44. http://dx.doi.org/10.1177/1753495x17745390.
Full textAbstract:
Kidney transplantation restores fertility in patients with end-stage renal disease, with many successful pregnancies after kidney transplantation being reported. However, there are little data regarding pregnancy in women transplanted under modern-era desensitisation protocols that utilise rituximab, plasma exchange and intravenous immunoglobulin, including ABO-incompatible transplants. Pregnancies in ABO-incompatible recipients can pose new challenges from an immunological perspective. Here, we report a case of successful pregnancy using in vitro fertilisation, in a renal transplant recipient who underwent desensitisation two years prior, that included use of rituximab and plasma exchange to receive an ABO-incompatible transplant from her husband and subsequent father of the baby. We believe this was the first case of successful pregnancy after ABO-incompatible kidney transplantation in Australia and New Zealand. This case also highlights the difficulties faced in conception following transplantation and demonstrates that in vitro fertilisation utilising ovulation induction can be successfully utilised for conception in this cohort. This recipient also had gestational diabetes, worsening renal function and preterm delivery which are important complications often seen in pregnancies of solid organ transplant recipients.
10
d’Emden, Michael, Donald McLeod, Jacobus Ungerer, Charles Appleton, and David Kanowski. "Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment." PLOS ONE 15, no. 12 (December 3, 2020): e0243192. http://dx.doi.org/10.1371/journal.pone.0243192.
Full textAbstract:
Objective To evaluate the role of fasting blood glucose (FBG) to minimise the use of the oral glucose tolerance test in pregnancy (POGTT) for the diagnosis of gestational diabetes mellitus (GDM). Research design and methods We analysed the POGTTs of 26,242 pregnant women in Queensland, Australia, performed between 1 January 2015 and 30 June 2015. A receiver operator characteristics (ROC) assessment was undertaken to indicate the FBG level that most effectively identified women at low risk of an abnormal result. Results There were 3,946 (15.0%) patients having GDM with 2,262 (8.6%) having FBG ≥ 5.1mmol/l. The ROC identified FBG levels >4.6mmol/l having the best specificity (77%) and sensitivity (54%) for elevated 1 and/or 2hr BGLs. There were 19,321 (73.7%) women having FBG < 4.7mmol/l with a prevalence of GDM of 4.0%, less than 1/3rd the overall rate. Only 4,638 (17.7%) women having FBGs from 4.7–5.0mmol/l would require further evaluation to confirm or exclude the diagnosis. Conclusion This contemporary study of women across the state of Queensland, Australia suggests the FBG can be used effectively to define glucose tolerance in pregnancy, minimising their contact with pathology laboratories and potential exposure to the corona virus. This analysis, used in conjunction with outcome data from the HAPO study, provides reassurance to women and their health professionals that FBG < 4.7mmol/l has both a low rate of abnormal glucose tolerance and minimal adverse pregnancy-associated complications.
Dissertations / Theses on the topic "Pregnancy Complications Australia"
1
Wakefield, Melanie. "Evaluation of a smoking cessation intervention for pregnant women and their partners attending a public hospital antenatal clinic." Adelaide : University of Adelaide, Dept. of Community Medicine, 1994. http://web4.library.adelaide.edu.au/theses/09PH/09phw147.pdf.
Full text
2
Wakefield, Melanie, and University of Adelaide Dept of Community Medicine. "Evaluation of a smoking cessation intervention for pregnant women and their partners attending a public hospital antenatal clinic / Melanie Wakefield." Adelaide : University of Adelaide, Dept. of Community Medicine, 1994. http://hdl.handle.net/2440/21562.
Full textAbstract:
Includes examples of information booklets as appendicesIncludes bibliographical references: p. 232-251
xiv, 251 p. : photo. ; 30 cm.
Title page, contents and abstract only. The complete thesis in print form is available from the University Library.
Thesis (Ph.D.)--University of Adelaide, Dept. of Community Medicine, 1994
3
Taylor, Josephine. "Vulvodynia and autoethnography." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2011. https://ro.ecu.edu.au/theses/367.
Full textAbstract:
The title of my thesis, Vulvodynia and Autoethnography, also describes its content: memoir that deals with chronic vulval pain and its place in society. The preface situates the thesis as a work of reflexive autoethnography and introduces vulvodynia (chronic vulval pain) as a condition of unexpected prevalence. An examination of possible reasons for the discrepancy between incidence and knowledge, introduced here, is a recurring theme in the text. The thesis is composed of creative and critical components that interweave and reflect upon each other. The first four chapters consist of chronological memoir, telling the story of the onset of my vulvodynia in 2000, and the derailment of my professional and personal lives. Two more life-narrative chapters are interspersed between the remainder. Weaving their way through the thesis are two chapter series: ‘Psychosomatic’ and ‘Nature of the Beast’. The Psychosomatic series explores the background to a common labelling of chronic genital pain in women (and men) as “psychosomatic” or “in the head”. The series examines the influence of the history of hysteria and psychoanalysis on medical attitudes toward such illnesses and demonstrates the incidence of vulval pain through recorded history. It suggests alternative readings of “psychosomatic” illness, looking at trauma theory and feminist body scholarship, among other fields, to expand possible interpretations of mind/body disorder. The Nature of the Beast series follows my journey through medicine, psychology, physiotherapy, alternative medicine and neuroscience as I try to understand and successfully treat my vulvodynia. The medical literature relating to vulvodynia is also surveyed, though this is secondary to the qualitative depiction of living with genital pain. Three interspersed chapters depict my wrestle with vulvodynia as it is reflected in, and prompted by, dreams and images. An exploration of such concepts as “virginity”, “teeth” (vagina dentata), and transforming the “mark” of vulval pain through the “mark” of writing, are contained within these chapters. They also contain a meditation on the matters this illness has forced me to confront, such as the place of sexuality and the possibility of meaning or faith in the context of debilitating pain. The thesis widens its scope to other women affected by vulval pain by telling the story of my appearance in a national magazine and the wave of response from over one hundred women. Some are represented through email and spoken comment. The voices of three women (aged around twenty-five, thirty-nine and eighty-eight) are duplicated through separate interview chapters. These chapters demonstrate the similarities, but also the significant differences, in our experience of vulval pain depending on age, lifestyle and individual coping styles. The whole body of research and writing forms an organic entity that arose and took shape, guided by unfolding life-events and inner processes
4
Joyce, Sarah Julia. "Demographic, clinical and environmental risk factors for prelabour rupture of membranes in Western Australia." University of Western Australia. School of Population Health, 2009. http://theses.library.uwa.edu.au/adt-WU2009.0126.
Full textAbstract:
[Truncated abstract] This thesis explores the risk factors and perinatal outcomes associated with prelabour rupture of membranes, with a particular focus on the environmental context. Prelabour rupture of membranes is defined as the rupture of fetal membranes before the onset of labour. It is a relatively common obstetric endpoint, occurring in approximately 8-10% of pregnant women at term (PROM) and in up to 40% of all preterm deliveries (pPROM). Despite the high prevalence of the condition, the biological mechanisms and risk factors, and in particular the role of environmental predictors, behind the development of PROM and pPROM remain largely unclear. A record-based prevalence design was used to analyse a population of 16,229 nulliparous, Caucasian women residing in Perth, Western Australia who gave birth to a single newborn during 2002-2004. Maternal age, socioeconomic status and threatened preterm labour during pregnancy were identified as risk factors for prelabour rupture of membranes. Term PROM was significantly associated with fetal distress (OR 1.19; 95%CI 1.00-1.43) and post-partum haemorrhage (OR 1.99; 95%CI 1.60-2.48). A number of perinatal complications were observed to be associated with the presentation of preterm PROM, including prolapsed cord (OR 13.95; 95%CI 4.57-42.61), ante-partum haemorrhage (OR 3.29; 95%CI 2.20-4.91), post-partum haemorrhage (OR 2.12; 95%CI 1.54-2.91), low birth weight (OR 17.79; 95%CI 13.87-22.82), very low birth weight (OR 20.01; 95%CI 14.12-28.35) and stillbirth (OR 5.42; 95%CI 2.87-10.21). However, the outcomes were similar between pPROM patients and other preterm deliveries, indicating that the complications arose due to the timing of the delivery. In contrast though, the risk factors between the two outcomes varied which may suggest that a different aetiological pathway exists between preterm PROM and other preterm deliveries. The frequency of complications decreased with increasing gestational age at delivery until the pregnancy reached full-term, whereupon an increase in gestational age at delivery resulted in an increased risk of fetal distress and post-partum haemorrhage. This finding is novel and may have important implications for the management of prelabour rupture of membranes, specifically with regard to the relative risks and benefits of expectant management (that is, the patient is admitted to an obstetric facility or hospital and closely monitored) versus planned delivery. ... This study represents the first attempt to investigate the potential associations between environmental risk factors and prelabour rupture of membranes. The results of the thesis provide a substantial contribution to our knowledge on prelabour rupture of membranes, including findings of direct relevance to clinical practice as well as a potentially contributing environmental exposure pathway. These original findings suggest a possible preventative approach to reducing the occurrence and associated morbidity of prelabour rupture of membranes may be feasible, and should be pursued if future research confirms the preliminary findings of this thesis.
Books on the topic "Pregnancy Complications Australia"
1
Slaytor, Emma K. Maternal deaths in Australia, 1997-1999. Canberra: Australian Institute of Health, 2004.
Find full text
2
Susan, Johnson. A better woman: [a memoir]. Milsons Point,NSW: Random House, 1999.
Find full text
3
A better woman: A memoir. New York: Washington Square Press, 2002.
Find full text
4
Cooper, Jacqui. Frozen Hope: My IVF Journey. Schwartz Publishing Pty, Limited, 2018.
Find full text
5
Winter, Cathy, The Royal The Royal Australian and New Zealand College of Obstetricians and Gynaecolo, and Timothy Draycott. PROMPT Course Manual: Australian-New Zealand Edition. University of Cambridge ESOL Examinations, 2020.
Find full textConference papers on the topic "Pregnancy Complications Australia"
1
Sitorukmi, Galuh, Bhisma Murti, and Yulia Lanti Retno Dewi. "Effect of Family History with Diabetes Mellitus on the Risk of Gestational Diabetes Mellitus: A Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.55.
Full textAbstract:
Background: Gestational diabetes mellitus (GDM) is a serious pregnancy complication, in which women without previously diagnosed diabetes develop chronic hyperglycemia during gestation. Studies have revealed that the family history of diabetes is an important risk factor for the gestational diabetes mellitus. The purpose of this study was to investigate effect of family history with diabetes mellitus on the risk of gestational diabetes mellitus. Subjects and Method: This was meta-analysis and systematic review. The study was conducted by collecting published articles from Pubmed, Google Scholar, Scopus, Science Direct, and Springer Link electronic databases, from year 2010 to 2020. Keywords used risk factor, gestational diabetes mellitus, family history, and cross-sectional. The inclusion criteria were full text, using English language, using cross-sectional study design, and reporting adjusted odds ratio. The study population was pregnant women. Intervention was family history of diabetes mellitus with comparison no family history of diabetes mellitus. The study outcome was gestational diabetes mellitus. The collected articles were selected by PRISMA flow chart. The quantitative data were analyzed by random effect model using Revman 5.3. Results: 7 studies from Ethiopia, Malaysia, Philippines, Peru, Australia, and Tanzania were selected for this study. This study reported that family history of diabetes mellitus increased the risk of gestational diabetes mellitus 2.91 times than without family history (aOR= 2.91; 95% CI= 2.08 to 4.08; p<0.001). Conclusion: Family history of diabetes mellitus increases the risk of gestational diabetes mellitus. Keywords: gestational diabetes mellitus, diabetes mellitus, family history Correspondence: Galuh Sitorukmi. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: galuh.sitorukmi1210@gmail.com. Mobile: 085799333013. DOI: https://doi.org/10.26911/the7thicph.05.55